Response to omalizumab in urticaria & asthma; Is it 'a life-time together' treatment?

Basit Öğe Kaydı
dc.contributor.authorKalpaklioglu, A. F.
dc.contributor.authorBaccioglu, A.
dc.contributor.authorCerit, A.
dc.date.accessioned2020-06-25T18:29:30Z
dc.date.available2020-06-25T18:29:30Z
dc.date.issued2018
dc.departmentKırıkkale Üniversitesi
dc.descriptionCongress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) -- MAY 26-30, 2018 -- Munich, GERMANY
dc.descriptionKalpaklioglu, A. Fusun/0000-0002-6548-6932
dc.description.abstract…en_US
dc.description.sponsorshipEuropean Acad Allergy & Clin Immunolen_US
dc.identifier.citationclosedAccessen_US
dc.identifier.endpage29en_US
dc.identifier.issn0105-4538
dc.identifier.issn1398-9995
dc.identifier.startpage29en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12587/7348
dc.identifier.volume73en_US
dc.identifier.wosWOS:000441690400048
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWileyen_US
dc.relation.ispartofAllergy
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleResponse to omalizumab in urticaria & asthma; Is it 'a life-time together' treatment?en_US
dc.typeConference Object

Dosyalar

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
Bildiri ve Sunum Koleksiyonu